Back

Genetic test yield in non-dilated left ventricular cardiomyopathy

29 August 2026 (14:15 - 15:00)
Organised by: Logo
Congress Presentation Part of: Epidemiology, prognosis, and outcomes in myocardial disease Epidemiology, Prognosis, Outcome ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Andrea Faggiano

IRCCS Ca Granda Foundation - Milan Polyclinic Maggiore Hospital, Milan (Italy)

6 More presentations in this session

Presentation thumbnail
A novel prediction model for heart failure-related death in hypertrophic cardiomyopathy
Doctor Y. Zhang (Beijing, CN)
Abstract
Presentation thumbnail
Lifetime risk of cardiomyopathy in the general population: a nationwide cohort study from Sweden
Doctor E. Linner (Lund, SE)
Abstract
Presentation thumbnail
Phenotype- and genotype-specific dominance of arrhythmic versus heart failure trajectories in inherited cardiomyopathies
Assistant Professor A. Antonopoulos (Athens, GR)
Abstract
Presentation thumbnail
Unmasking risk in asymptomatic hypertrophic cardiomyopathy: clinical and multimodality imaging determinants of disease progression and adverse outcomes
Doctor S. Keen (Cleveland, US)
Abstract
Presentation thumbnail
Machine-learning clustering uncovers divergent response pathways to mavacamten in obstructive HCM: a portuguese multicentre perspective
Doctor I. Miranda (Amadora, PT)
Abstract

Access the full session

Session thumbnail
Epidemiology, prognosis, and outcomes in myocardial disease

The Event

Event poster

ESC Congress 2026

29 August 2026 14:15 CET
You may be interested in
thumbnail
Congress Presentation
Impact of genetic testing on the management in patients with idiopathic dilated cardiomyopathy
30 June 2021
thumbnail
Congress Presentation
Overlap in scarring phenotypes between non-dilated left ventricular cardiomyopathy and arrhythmogenic left ventricular cardiomyopathy: Implications for prognostic stratification
31 August 2025
thumbnail
Congress Presentation
Phenotypic predictors of pathogenic variants in probands with hypertrophic cardiomyopathy
28 August 2022
thumbnail
Congress Presentation
The added value of contrast-enhanced cardiac magnetic resonance to predict positive genetic testing in clinically suspected Lamin A/C cardiomyopathy
28 August 2020

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources